期刊文献+

直肠间质瘤40例临床病理特点和外科治疗 被引量:2

The Clinical Pathological Features and Surgical Treatment of Rectal Stromal Tumors in 40 Cases
原文传递
导出
摘要 为探讨直肠间质瘤的临床表现、组织学、免疫组化特点、外科治疗和预后,对收治的40例直肠间质瘤的临床及病理资料进行回顾性分析。将肿瘤侵袭危险度分为无恶性(norisk,NR)、低度恶性(10wrisk,LR)、高度恶性(highrisk,HR)3组,采用Kaplan-Meier限乘法计算生存率及单因素分析,并用Cox多因素回归分析评估患者预后影响因素。结果显示,免疫组化C-kit阳性表达率为82.5%,中位生存时间为52.5个月,术后1、3及5年生存率分别为82.5%、60.0%及42.5%。侵袭危险度评估分级与患者顶后密切相关(P=0.016)。结果表明,直肠间质瘤治疗仍以外科治疗为主,肿瘤侵袭危险度是影响预后的高危因素。 In order to explore the clinical manifestation, histology and immunohistochemistry,as well as surgcial treatment and prognosis of rectal stromal tumors(RST), authors retrospectively analysed the 40 patient's clinical and pathological data, as: differentiate the risk degrees of neoplasm invasion as no risk (NR) ,low risk(LR) and high risk(HR), then take Kaplan-Meier limited multiplication method to calcu- late survival rate and make single-factor analysis, and by using Cox multi-factor regression analysis evaluate the influence factors on patient's prognosis.As results,immunohistochemistry c-kit positive expression rate was 82.5 %, median survival time was 52.5 months, 1,3 and 5-year postoperative survival rate respectively was 82.5%,60.0% and 42.5%, and the evaluation grading of invasive risk degree was closely related to patient's prognosis( P = 0.016).Results show that for RST surgery still is of main therapy,the risk degree of neoplasm invasion is high-risk factors influencing prognosis.
出处 《中国肛肠病杂志》 2015年第8期7-9,共3页 Chinese Journal of Coloproctology
关键词 胃肠道间质瘤 直肠 病理学 外科治疗 Gastrointestinal stromal tumor Rectum Pathology Surgical treatment
  • 相关文献

参考文献5

二级参考文献65

  • 1万远廉,汤坚强,柳萍,刘玉村,汪欣,吴涛,潘义生,黄莚庭.直肠间质瘤16例临床病理分析[J].中华外科杂志,2004,42(15):897-900. 被引量:17
  • 2伍小军,万德森,潘志忠,周志伟,陈功,李力人,卢震海,丁培荣.胃肠道间质瘤大小与预后[J].肿瘤研究与临床,2006,18(8):520-524. 被引量:9
  • 3Miettinen M, Lasota J. Gastrointestinal stromal tumorsdefinition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch, 2001, 438: 1-12.
  • 4Changchien CR, Wu MC, Tasi WS, et al. Evaluation of prognosis for malignant rectal gastrointestinal stromal tumor by clinical parameters and immunohistochemical staining. Dis Colon Rectum, 2004, 47 : 1922-1929.
  • 5Logrono R, Jones DV, Faruqi S, et al. Recent advances in cell biology, diagnosis, and therapy of gastrointestinal stromal tumor(GIST). Cancer Biol Ther, 2004, 3:251-258.
  • 6Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol, 2002, 33:459-465.
  • 7DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors : Recurrence patterns and prognostic factors for survival. Ann Surg, 2000, 231:51-58.
  • 8Pierie JP, Choudry U, Muzlknnsky A, et al. The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg, 2001, 136:383-389.
  • 9Mudan SS, Conlon KC, Woodruff JM, et al. Salvage surgery for patients with recurrent gastrointestinal sarcoma: Prognostic factor to guide patient selection. Cancer, 2000, 88:66-74.
  • 10Demetri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med, 2002, 347:472-480.

共引文献15

同被引文献17

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部